234 related articles for article (PubMed ID: 23300802)
1. PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohn's disease and affect NF-κB and XBP1 binding sites.
Glas J; Seiderer J; Czamara D; Pasciuto G; Diegelmann J; Wetzke M; Olszak T; Wolf C; Müller-Myhsok B; Balschun T; Achkar JP; Kamboh MI; Franke A; Duerr RH; Brand S
PLoS One; 2012; 7(12):e52873. PubMed ID: 23300802
[TBL] [Abstract][Full Text] [Related]
2. PTGER4 modulating variants in Crohn's disease.
Prager M; Büttner J; Büning C
Int J Colorectal Dis; 2014 Aug; 29(8):909-15. PubMed ID: 24793213
[TBL] [Abstract][Full Text] [Related]
3. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4.
Libioulle C; Louis E; Hansoul S; Sandor C; Farnir F; Franchimont D; Vermeire S; Dewit O; de Vos M; Dixon A; Demarche B; Gut I; Heath S; Foglio M; Liang L; Laukens D; Mni M; Zelenika D; Van Gossum A; Rutgeerts P; Belaiche J; Lathrop M; Georges M
PLoS Genet; 2007 Apr; 3(4):e58. PubMed ID: 17447842
[TBL] [Abstract][Full Text] [Related]
4. PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background.
Glas J; Wagner J; Seiderer J; Olszak T; Wetzke M; Beigel F; Tillack C; Stallhofer J; Friedrich M; Steib C; Göke B; Ochsenkühn T; Karbalai N; Diegelmann J; Czamara D; Brand S
PLoS One; 2012; 7(3):e33682. PubMed ID: 22457781
[TBL] [Abstract][Full Text] [Related]
5. Study of chromosomal region 5p13.1 in Crohn's disease, ulcerative colitis, and rheumatoid arthritis.
Perdigones N; Martín E; Robledo G; Lamas JR; Taxonera C; Díaz-Rubio M; de la Concha EG; López-Nevot MA; García A; Gómez-García M; Fernández-Gutiérrez B; Martín J; Urcelay E
Hum Immunol; 2010 Aug; 71(8):826-8. PubMed ID: 20561984
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease.
Brant SR; Okou DT; Simpson CL; Cutler DJ; Haritunians T; Bradfield JP; Chopra P; Prince J; Begum F; Kumar A; Huang C; Venkateswaran S; Datta LW; Wei Z; Thomas K; Herrinton LJ; Klapproth JA; Quiros AJ; Seminerio J; Liu Z; Alexander JS; Baldassano RN; Dudley-Brown S; Cross RK; Dassopoulos T; Denson LA; Dhere TA; Dryden GW; Hanson JS; Hou JK; Hussain SZ; Hyams JS; Isaacs KL; Kader H; Kappelman MD; Katz J; Kellermayer R; Kirschner BS; Kuemmerle JF; Kwon JH; Lazarev M; Li E; Mack D; Mannon P; Moulton DE; Newberry RD; Osuntokun BO; Patel AS; Saeed SA; Targan SR; Valentine JF; Wang MH; Zonca M; Rioux JD; Duerr RH; Silverberg MS; Cho JH; Hakonarson H; Zwick ME; McGovern DP; Kugathasan S
Gastroenterology; 2017 Jan; 152(1):206-217.e2. PubMed ID: 27693347
[TBL] [Abstract][Full Text] [Related]
7. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
8. rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.
Glas J; Seiderer J; Pasciuto G; Tillack C; Diegelmann J; Pfennig S; Konrad A; Schmechel S; Wetzke M; Török HP; Stallhofer J; Jürgens M; Griga T; Klein W; Epplen JT; Schiemann U; Mussack T; Lohse P; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Mar; 104(3):665-72. PubMed ID: 19262523
[TBL] [Abstract][Full Text] [Related]
9. Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort.
Weersma RK; Stokkers PC; Cleynen I; Wolfkamp SC; Henckaerts L; Schreiber S; Dijkstra G; Franke A; Nolte IM; Rutgeerts P; Wijmenga C; Vermeire S
Am J Gastroenterol; 2009 Mar; 104(3):630-8. PubMed ID: 19174780
[TBL] [Abstract][Full Text] [Related]
10. IRGM variants and susceptibility to inflammatory bowel disease in the German population.
Glas J; Seiderer J; Bues S; Stallhofer J; Fries C; Olszak T; Tsekeri E; Wetzke M; Beigel F; Steib C; Friedrich M; Göke B; Diegelmann J; Czamara D; Brand S
PLoS One; 2013; 8(1):e54338. PubMed ID: 23365659
[TBL] [Abstract][Full Text] [Related]
11. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5.
Prescott NJ; Fisher SA; Franke A; Hampe J; Onnie CM; Soars D; Bagnall R; Mirza MM; Sanderson J; Forbes A; Mansfield JC; Lewis CM; Schreiber S; Mathew CG
Gastroenterology; 2007 May; 132(5):1665-71. PubMed ID: 17484864
[TBL] [Abstract][Full Text] [Related]
12. Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.
Diegelmann J; Czamara D; Le Bras E; Zimmermann E; Olszak T; Bedynek A; Göke B; Franke A; Glas J; Brand S
PLoS One; 2013; 8(11):e77773. PubMed ID: 24223725
[TBL] [Abstract][Full Text] [Related]
13. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
14. The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.
Glas J; Seiderer J; Bayrle C; Wetzke M; Fries C; Tillack C; Olszak T; Beigel F; Steib C; Friedrich M; Diegelmann J; Czamara D; Brand S
PLoS One; 2011; 6(12):e29309. PubMed ID: 22242114
[TBL] [Abstract][Full Text] [Related]
15. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
[TBL] [Abstract][Full Text] [Related]
16. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
[TBL] [Abstract][Full Text] [Related]
17. Investigation of multiple susceptibility loci for inflammatory bowel disease in an Italian cohort of patients.
Latiano A; Palmieri O; Latiano T; Corritore G; Bossa F; Martino G; Biscaglia G; Scimeca D; Valvano MR; Pastore M; Marseglia A; D'Incà R; Andriulli A; Annese V
PLoS One; 2011; 6(7):e22688. PubMed ID: 21818367
[TBL] [Abstract][Full Text] [Related]
18. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients.
Yamazaki K; Onouchi Y; Takazoe M; Kubo M; Nakamura Y; Hata A
J Hum Genet; 2007; 52(7):575-583. PubMed ID: 17534574
[TBL] [Abstract][Full Text] [Related]
19. Pregnane X receptor (PXR/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel disease.
Glas J; Seiderer J; Fischer D; Tengler B; Pfennig S; Wetzke M; Beigel F; Olszak T; Weidinger M; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Diegelmann J; Czamara D; Brand S
Inflamm Bowel Dis; 2011 Sep; 17(9):1917-24. PubMed ID: 21830270
[TBL] [Abstract][Full Text] [Related]
20. Candidate polymorphisms and susceptibility to inflammatory bowel disease: A systematic review and meta-analysis.
Tang L; Xu M
Gene; 2020 Aug; 753():144814. PubMed ID: 32464244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
